Teva Pharmaceutical (Germany) Investor Sentiment

TEV Stock   14.75  0.10  0.67%   
Slightly above 62% of Teva Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Teva Pharmaceutical Industries suggests that many traders are alarmed regarding Teva Pharmaceutical's prospects. Teva Pharmaceutical's investing sentiment can be driven by a variety of factors including economic data, Teva Pharmaceutical's earnings reports, geopolitical events, and overall market trends.
  
a day ago at news.google.com         
Teva Pharmaceutical Industries Limited Shares Sold by Swiss National Bank - MarketBeat
Google News at Macroaxis
3 days ago at news.google.com         
Teva Pharmaceutical Industries Limited Stock Position Raised by Zurcher Kantonalbank Zurich Cantonal...
Google News at Macroaxis
few days ago at news.google.com         
Raymond James Financial Inc. Invests 38.91 Million in Teva Pharmaceutical Industries Limited - Marke...
Google News at Macroaxis
few days ago at news.google.com         
Zacks Research Issues Pessimistic Outlook for TEVA Earnings - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Why Teva Pharmaceutical Stock Is Sinking Today - The Motley Fool
Google News at Macroaxis
over two months ago at news.google.com         
US analysts list Israeli giants Teva, Wix in 2025 top picks - The Jerusalem Post
Google News at Macroaxis
over two months ago at news.google.com         
US analysts list Teva, Wix in 2025 top picks -
Google News at Macroaxis
over six months ago at news.google.com         
Bellevue Group AG Purchases New Position in Teva Pharmaceutical Industries Limited - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceuticals stock climbs as schizophrenia treatment shows promise - MarketWatch
Google News at Macroaxis
over six months ago at news.google.com         
Wellington Management Group LLP Increases Stock Position in Teva Pharmaceutical Industries Limited -...
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Potential Outweighs Concerns - Seeking Alpha
Google News at Macroaxis
over a year ago at news.google.com         
Short Interest in Teva Pharmaceutical Industries Limited NYSE ... - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
Global Acute Agitation and Aggression Treatment Market is ... - GlobeNewswire
Google News at Macroaxis
over a year ago at news.google.com         
Teva Pharmaceutical Industries Limited short interest ... - Best Stocks
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Teva Pharmaceutical that are available to investors today. That information is available publicly through Teva media outlets and privately through word of mouth or via Teva internal channels. However, regardless of the origin, that massive amount of Teva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teva Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teva Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teva Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teva Pharmaceutical alpha.

Teva Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Teva Stock Analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.